Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals
Sarris J, Ravindran A, Yatham LN
Published in World Journal of Biological Psychiatry
Methodology
International taskforce evidence review and clinical guideline on nutraceuticals in psychiatry.
Key Findings
Provisional support for adjunctive omega-3 and NAC in bipolar depression; explicit caution that monotherapy is not supported and that some agents may destabilise mood.
Conclusions
Nutraceuticals are adjuncts only in bipolar disorder and must not replace mood stabilisers.
Limitations
Guideline synthesis; evidence quality varies widely by agent.
Supplements Studied
Provisional support for adjunctive NAC in bipolar depression; monotherapy is not supported.
Outcomes Measured
Nutraceuticals are adjuncts only and must not replace mood stabilisers.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.